Brokerage firm Jefferies had upgraded Biocon last week to “hold” from its earlier rating of “underperform” and raised its price target to ₹400 from ₹280 earlier.
Brokerage firm Jefferies had upgraded Biocon last week to “hold” from its earlier rating of “underperform” and raised its price target to ₹400 from ₹280 earlier.